Overview
GERD affects approximately 20% of the US adult population, characterized by chronic acid reflux that damages the esophageal lining. While proton pump inhibitors remain first-line therapy, several supplements have shown promise in clinical trials for reducing reflux frequency, protecting esophageal mucosa, and supporting digestive function.



